Less is More: Medicines that Require Less Frequent Administration Improve Adherence, but Are They Better? Dyfrig Hughes Editorial 11 October 2012 Pages: 211 - 213
Aromatase Inhibitors in Breast Cancer Jonathan Karnon Review Article 11 October 2012 Pages: 215 - 232
Trends in Outpatient Prescription Drug Use and Related Costs in the US Diane K. WysowskiLaura A. GovernaleJoslyn Swann Short Communication 11 October 2012 Pages: 233 - 236
Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy Jonathan KarnonThomas DeleaPaul E. Goss Original Research Article 11 October 2012 Pages: 237 - 250
Cost Considerations in the Medical Management of Glaucoma in the US Lawrence D. GoldbergJohn Walt Original Research Article 11 October 2012 Pages: 251 - 264
Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer’s Disease and Other Dementias Jerrold HillHoward FillitSobin Chang Original Research Article 11 October 2012 Pages: 265 - 280
Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women Richard J. MilneKathy H. Heaton-BrownAlison Cubitt Original Research Article 11 October 2012 Pages: 281 - 292
Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States A. Simon PickardDeborah DobrezDavid Cella Correspondence 11 October 2012 Pages: 293 - 294
Bimatoprost Greg L. PloskerSusan J. Keam Adis Pharmacoeconomic Drug Evaluation 11 October 2012 Pages: 297 - 314